Use of infliximab to treat psoriatic arthritis in HIV-positive patients

Psoriatic arthritis in HIV-positive patients is not only severe, but also raises specific treatment challenges, as immunosuppressant and immunomodulating agents may adversely affect both the course of the HIV infection and the risk of opportunistic infections.

infliximab.pdf 95K Descargar documento